Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00422305 · ClinicalTrials.gov registry record
Assessment of Lung Structure and Function of Infants Born Prematurely
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 104
- Enrollment target
NCT00422305: Completed study, sponsored by Indiana University.
NCT00422305 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00422305 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the growth of the lung and how easily gas can be taken up by the lung in healthy infants born at full term without any breathing problems and infants born prematurely.
Primary Outcome
Forced expiratory Flows, Single-breath diffusion capacity and alveolar volume
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2007-01 |
| Est. Completion | 2019-01 |
What the finished NCT00422305 record still lists
NCT00422305 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00422305 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00422305 about?
NCT00422305 is a clinical study titled "Assessment of Lung Structure and Function of Infants Born Prematurely". The purpose of this study is to evaluate the growth of the lung and how easily gas can be taken up by the lung in healthy infants born at full term without any breathing problems and infants born prematurely.
What is the current status of trial NCT00422305?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2007-01. Estimated completion is 2019-01.
Who is sponsoring clinical trial NCT00422305?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia